| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 257 | 0 | 50.216 | 62.406 | 35.316 | 99.340 | 109.180 | 110.113 |
| Total Income - EUR | - | 0 | 257 | 0 | 50.352 | 62.891 | 36.039 | 100.791 | 145.854 | 125.802 |
| Total Expenses - EUR | - | 1.373 | 407 | 320 | 10.663 | 19.183 | 13.125 | 25.760 | 28.645 | 32.709 |
| Gross Profit/Loss - EUR | - | -1.373 | -150 | -320 | 39.689 | 43.708 | 22.913 | 75.031 | 117.208 | 93.093 |
| Net Profit/Loss - EUR | - | -1.373 | -159 | -320 | 39.183 | 43.008 | 22.516 | 74.182 | 115.828 | 89.395 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cbsintensivmedical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 9.744 | 25.597 | 19.759 | 13.957 | 8.026 | 56.950 |
| Current Assets | - | 222 | 248 | -10 | 29.151 | 48.850 | 76.394 | 156.569 | 278.719 | 96.992 |
| Inventories | - | 0 | 0 | 0 | 766 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 7.780 | 259 | 8.980 | 699 | 1.078 | 81.294 |
| Cash | - | 222 | 248 | -10 | 20.605 | 48.590 | 62.667 | 148.264 | 275.446 | 15.699 |
| Shareholders Funds | - | -1.328 | -1.464 | -1.757 | 37.460 | 73.947 | 94.823 | 169.299 | 284.613 | 89.444 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.550 | 1.713 | 1.747 | 1.435 | 499 | 1.330 | 1.227 | 2.132 | 64.499 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Cbsintensivmedical S.r.l.